LEADER 00811nam1-22002651i-450 
001 990003096810403321
005 20190314135931.0
010   $a0-444-85144-5
100   $a20000920d1979----km-y0itay50------ba
101 0 $aeng
102   $aIT
200 1 $aIncentives in Public Decision-Making$fJerry R. Green, Jean-Jacques Laffont.
210   $aAmsterdam$cNorth-Holland$d1979.
215   $aXVIII, 293 p.$d25 cm
225 1 $aStudies in Public Economics$v1
610 0 $aDecisioni$aEconomia pubblica
700  1$aGreen,$bJerry R.$089352
701  1$aLaffont,$bJean-Jacques$f<1947-2004>$088913
801  0$aIT$bUNINA$gRICA$2UNIMARC
901   $aBK
912   $a990003096810403321
952   $aN/0 GRE$b9670/I$fSES
959   $aSES
996   $aIncentives in Public Decision-Making$9459880
997   $aUNINA

LEADER 03428nam  2200985z- 450 
001 9910566483503321
005 20220506
035   $a(CKB)5680000000037545
035   $a(oapen)https://directory.doabooks.org/handle/20.500.12854/80996
035   $a(oapen)doab80996
035   $a(EXLCZ)995680000000037545
100   $a20202205d2022      |y         0
101 0 $aeng
135   $aurmn|---annan
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aClostridioides difficile Infection
210   $aBasel$cMDPI - Multidisciplinary Digital Publishing Institute$d2022
215   $a1 online resource (178 p.)
311 08$a3-0365-3878-X 
311 08$a3-0365-3877-1 
330   $aThis book collects multidisciplinary research articles focused on Clostridioides difficile infection. The contributions collected here shed some light on grey areas of our knowledge of Clostridioides difficile, including regional Clostridioides difficile phenotypic and genotypic patterns, the Clostridioides difficile infection clinical course and the mortality rate in different settings and patient case-mix, the levels of Clostridioides difficile toxins in patients' sera, and novel, promising therapeutic approaches. This collection serves as a valuable reservoir of knowledge for scientists and researchers in the field of infectious diseases.
606   $aEpidemiology and Medical statistics$2bicssc
606   $aMedicine and Nursing$2bicssc
610   $a16S rRNA
610   $aanti-spore
610   $aantibacterial
610   $aantibiotic resistance
610   $aantibiotics
610   $abaicalin
610   $abovine immunoglobulins
610   $aC. difficile
610   $aC. difficile infection
610   $aCDI
610   $aCDI severity
610   $aCharlson comorbidity index
610   $aChild-Pugh score
610   $aClostridioides (Clostridium) difficile
610   $aClostridioides difficile
610   $aClostridioides difficile associated disease
610   $aClostridioides difficile infection
610   $aClostridium difficile
610   $aco-morbidities
610   $agut dysbiosis
610   $ahamsters
610   $amalignancy
610   $amethod
610   $amicrobiome
610   $amolecular analysis
610   $amortality
610   $amouse model
610   $amulti-step algorithm
610   $amultiplex "real-time" PCR
610   $an/a
610   $aNAFLD
610   $ananomaterial
610   $aNASH
610   $anext generation sequencing
610   $anonalcoholic fatty liver disease
610   $aoutcome
610   $aPCR capillary-based electrophoresis ribotyping
610   $apeptidomimetic
610   $aplasma
610   $aquantification
610   $arecurrent disease
610   $arisk factors
610   $aspore
610   $aspore germination
610   $aspores
610   $aTcdA
610   $aTcdB
610   $ateicoplanin
610   $atoxemia
610   $atoxin
610   $atoxin production
610   $atriazole
615  7$aEpidemiology and Medical statistics
615  7$aMedicine and Nursing
700   $aGranata$b Guido$4edt$0482312
702   $aGranata$b Guido$4oth
906   $aBOOK
912   $a9910566483503321
996   $aClostridioides difficile Infection$93029473
997   $aUNINA